Bacterial pneumonia primary prevention: Difference between revisions
No edit summary |
|||
| Line 51: | Line 51: | ||
| | | | ||
* All patients above the age of 65 | * All patients above the age of 65 | ||
* Very high risk patients below the age of 65 | * Very high-risk patients below the age of 65 | ||
# Sickle cell disease and asplenia | # Sickle cell disease and asplenia | ||
# Immunocompromised | # Immunocompromised patient | ||
# Chronic kidney disease | # Chronic kidney disease | ||
# CSF fluid leaks | # CSF fluid leaks | ||
| Line 62: | Line 62: | ||
=Controlling Underlying Comorbidities and Patient Education= | =Controlling Underlying Comorbidities and Patient Education= | ||
<ref name="pmid30020693">{{cite journal| author=| title=StatPearls | journal= | year= 2022 | volume= | issue= | pages= | pmid=30020693 | doi= | pmc= | url= }} </ref> | |||
* Comorbidities significantly increase the risk of bacterial pneumonia and should be controlled to aid in prevention | |||
* Strict blood glucose and blood pressure control | |||
* Smoking Cessation | |||
* Abstaining from alcohol overuse | |||
* Maintaining good dental hygiene | |||
* The elderly and immunocompromised should consider medical assistance if they develop worrisome symptoms such as a fever accompanied by dyspnea and rigors | |||
<br /> | <br /> | ||
=Conditions Requiring Prophylaxis= | =Conditions Requiring Prophylaxis= | ||
Revision as of 07:54, 12 January 2022
|
Bacterial pneumonia Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Bacterial pneumonia primary prevention On the Web |
|
American Roentgen Ray Society Images of Bacterial pneumonia primary prevention |
|
Risk calculators and risk factors for Bacterial pneumonia primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Arooj Naz
Overview
The goal of Primary prevention is to prevent the occurrence of an illness or a disease before it ever occurs. In the case of bacterial pneumonia, primary prevention can be achieved by the administration of vaccination as well as attempting to control underlying comorbidities that may predispose an individual to pneumonia. When certain conditions are present, it may also be helpful to treat with prophylactic antibiotics.[1] Educating the public as well as identifying those most susceptible to infection can help reduce the risk of pneumonia.
Vaccination
-Routinely administered vaccines include:
- Pneumococcus (Intramuscular Conjugate or polysaccharide vaccine)
- Annual vaccine against H. influenza(Intramusuclar killed vaccine)
| Advantages | Disadvanatges | Indications | |
|---|---|---|---|
| PCV13 (Conjugate vaccine) |
|
|
|
| PPSV23 (Polysaccharide vaccine) |
|
|
|
| PCV13 + PPSV23 |
|
Controlling Underlying Comorbidities and Patient Education
- Comorbidities significantly increase the risk of bacterial pneumonia and should be controlled to aid in prevention
- Strict blood glucose and blood pressure control
- Smoking Cessation
- Abstaining from alcohol overuse
- Maintaining good dental hygiene
- The elderly and immunocompromised should consider medical assistance if they develop worrisome symptoms such as a fever accompanied by dyspnea and rigors
Conditions Requiring Prophylaxis
References
- ↑ https://www.cdc.gov/pneumococcal/clinicians/prevention.html. Missing or empty
|title=(help) - ↑ Hayward S, Thompson LA, McEachern A (2016). "Is 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Combined With 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) Superior to PPSV23 Alone for Reducing Incidence or Severity of Pneumonia in Older Adults? A Clin-IQ". J Patient Cent Res Rev. 3 (2): 111–115. doi:10.17294/2330-0698.1214. PMC 4927079. PMID 27376105.
- ↑ Grief SN, Loza JK (2018). "Guidelines for the Evaluation and Treatment of Pneumonia". Prim Care. 45 (3): 485–503. doi:10.1016/j.pop.2018.04.001. PMC 7112285 Check
|pmc=value (help). PMID 30115336. - ↑ "StatPearls". 2022. PMID 30020693.